Clinical Gastroenterology and Hepatology
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
Inflammatory Bowel Disease: Resource Utilization During Pediatric to Adult Transfer
2011
-
Medical Therapy for Acute Severe Ulcerative Colitis: A Systematic Review With Meta-analysis..
S1542-3565(25)00329-5.
2025
-
Hypercoagulation after Hospital Discharge in Acute Severe Ulcerative Colitis: A Prospective Study..
S1542-3565(24)01085-1.
2024
-
Defining Endoscopic Remission in Crohn’s Disease: MM-SES-CD and SES-CD Thresholds Associated With Low Risk of Disease Progression.
22:1687-1696.e6.
2024
-
Comparative Efficacy of Advanced Therapies for Achieving Endoscopic Outcomes in Crohn’s Disease: A Systematic Review and Network Meta-Analysis.
22:1190-1199.e15.
2024
-
Novel Irritable Bowel Syndrome Subgroups are Reproducible in the Global Adult Population.
23:1039-1048.e7.
2024
-
Environmental Factors Associated with Risk of Crohn’s Disease Development in the Crohn’s and Colitis Canada - Genetic, Environmental, Microbial Project.
22:1889-1897.e12.
2024
-
Delayed Ustekinumab Responders in Ulcerative Colitis Have Greater Inflammatory Burden but Similar Outcomes as Early Responders.
21:3387-3396.e1.
2023
-
Associations of Antibiotics, Hormonal Therapies, Oral Contraceptives, and Long-Term NSAIDS With Inflammatory Bowel Disease: Results From the Prospective Urban Rural Epidemiology (PURE) Study.
21:2649-2659.e16.
2023
-
Food Processing and Risk of Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
21:2483-2495.e1.
2023
-
What is the Prevalence of Clinically Significant Endoscopic Findings in Subjects With Dyspepsia? Updated Systematic Review and Meta-analysis.
21:1739-1749.e2.
2023
-
Predictors of Placebo Induction Response and Remission in Ulcerative Colitis.
21:1050-1060.e9.
2023
-
Comparative Efficacy and Rapidity of Action for Infliximab vs Ustekinumab in Biologic Naïve Crohn’s Disease.
20:1579-1587.e2.
2022
-
Comparative Efficacy for Infliximab Vs Vedolizumab in Biologic Naive Ulcerative Colitis.
20:1588-1597.e3.
2022
-
Correction..
20:1423.
2022
-
Reply.
20:e1510-e1511.
2022
-
Clinical Decision Support Tool for Infliximab in Crohn’s Disease.
20:e1192-e1195.
2022
-
Early Change in Epithelial Neutrophilic Infiltrate Predicts Long-Term Response to Biologics in Ulcerative Colitis.
20:1095-1104.e9.
2022
-
Greater Overlap of Rome IV Disorders of Gut-Brain Interactions Leads to Increased Disease Severity and Poorer Quality of Life.
20:e945-e956.
2022
-
Reply.
20:e1216-e1217.
2022
-
Feasibility and Safety of Tethered Capsule Endomicroscopy in Patients With Barrett’s Esophagus in a Multi-Center Study.
20:756-765.e3.
2022
-
Gluten-Free Diet Reduces Symptoms, Particularly Diarrhea, in Patients With Irritable Bowel Syndrome and Antigliadin IgG.
19:2343-2352.e8.
2021
-
Digestive Manifestations in Patients Hospitalized With Coronavirus Disease 2019.
19:1355-1365.e4.
2021
-
Reply.
19:1511-1511.
2021
-
A High Serum Level of Taurocholic Acid Is Correlated With the Severity and Resolution of Drug-induced Liver Injury.
19:1009-1019.e11.
2021
-
Active Margins, Plexitis, and Granulomas Increase Postoperative Crohn’s Recurrence: Systematic Review and Meta-analysis.
19:451-462.
2021
-
Real-World Gluten Exposure in Patients With Celiac Disease on Gluten-Free Diets, Determined From Gliadin Immunogenic Peptides in Urine and Fecal Samples.
19:484-491.e1.
2021
-
Effect of Concomitant Therapy With Steroids and Tumor Necrosis Factor Antagonists for Induction of Remission in Patients With Crohn’s Disease: A Systematic Review and Pooled Meta-analysis.
19:238-245.e4.
2021
-
The Risk of Contracting COVID-19 Is Not Increased in Patients With Celiac Disease.
19:391-393.
2021
-
Leaving No Stone Unturned in the Search for Adverse Events Associated With Use of Proton Pump Inhibitors.
19:41-42.
2021
-
Managing Inflammatory Bowel Disease During COVID-19: Summary of Recommendations from Gastrointestinal Societies.
18:2143-2146.
2020
-
Canadian Association of Gastroenterology Clinical Practice Guideline on the Management of Bile Acid Diarrhea.
18:24-41.e1.
2020
-
Association Between Helicobacter pylori Exposure and Decreased Odds of Eosinophilic Esophagitis—A Systematic Review and Meta-analysis.
17:2185-2198.e3.
2019
-
Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Luminal Crohn’s Disease.
17:1680-1713.
2019
-
Variation in Endoscopic Activity Assessment and Endoscopy Score Validation in Adults With Eosinophilic Esophagitis.
17:1477-1488.e10.
2019
-
Complete Resolution of Nonalcoholic Fatty Liver Disease After Bariatric Surgery: A Systematic Review and Meta-analysis.
17:1040-1060.e11.
2019
-
Reply.
17:1007-1007.
2019
-
Patient-Reported Outcomes and Endoscopic Appearance of Ulcerative Colitis: A Systematic Review and Meta-analysis.
17:411-418.e3.
2019
-
Gastric Cancer as Preventable Disease.
15:1833-1843.
2017
-
White Paper AGA: Functional Dyspepsia.
15:1191-1194.
2017
-
Major Gastrointestinal Bleeding Often Is Caused by Occult Malignancy in Patients Receiving Warfarin or Dabigatran to Prevent Stroke and Systemic Embolism From Atrial Fibrillation.
15:682-690.
2017
-
Reply.
14:1672-1672.
2016
-
A Model to Identify Sarcopenia in Patients With Cirrhosis.
14:1473-1480.e3.
2016
-
Mucosal Healing Is Associated With Improved Long-term Outcomes of Patients With Ulcerative Colitis: A Systematic Review and Meta-analysis.
14:1245-1255.e8.
2016
-
Reply.
14:1361-1362.
2016
-
Antidepressants for Functional Dyspepsia: New Indications for Old Therapies?.
14:393-394.
2016
-
The Probiotic VSL#3 Has Anti-inflammatory Effects and Could Reduce Endoscopic Recurrence After Surgery for Crohn's Disease.
13:928-935.e2.
2015
-
Partner Burden in Irritable Bowel Syndrome.
11:151-155.
2013
-
Efficacy of Topical 5-Aminosalicylates in Preventing Relapse of Quiescent Ulcerative Colitis: A Meta-analysis.
10:513-519.
2012
-
Acid Suppression for Reflux Disease: “Off-the-Peg” or a Tailored Approach?.
10:210-213.
2012
-
Management of Patients With Nonvariceal Upper Gastrointestinal Bleeding.
10:234-239.
2012
-
Low Doses of Acetylsalicylic Acid Increase Risk of Gastrointestinal Bleeding in a Meta-Analysis.
9:762-768.e6.
2011
-
Gastroesophageal Reflux Symptoms in Patients With Celiac Disease and the Effects of a Gluten-Free Diet.
9:214-219.
2011
-
What Is the Prevalence of Clinically Significant Endoscopic Findings in Subjects With Dyspepsia? Systematic Review and Meta-analysis.
8:830-837.e2.
2010
-
Liver Cirrhosis Is Associated With Venous Thromboembolism Among Hospitalized Patients in a Nationwide US Study.
8:800-805.e1.
2010
-
Prevalence, Diagnosis, and Profile of Autoimmune Pancreatitis Presenting With Features of Acute or Chronic Pancreatitis.
8:639-640.
2010
-
Spontaneous Intramural Esophageal Hematoma in Association With Idiopathic Thrombocytopenic Purpura: A Cause of Non-Cardiac Chest Pain.
8:e73-e74.
2010
-
Systematic Review and Meta-analysis of the Prevalence of Irritable Bowel Syndrome in Individuals With Dyspepsia.
8:401-409.
2010
-
“Power” of Selective Serotonin Reuptake Inhibitors in Irritable Bowel Syndrome.
8:313-314.
2010
-
Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: Systematic Review and Meta-analysis.
7:1279-1286.
2009
-
Low-Dose Aspirin Affects the Small Bowel Mucosa: Results of a Pilot Study With a Multidimensional Assessment.
7:524-529.
2009
-
Not All Side Effects Associated With Tricyclic Antidepressant Therapy Are True Side Effects.
7:446-451.
2009
-
Postinfectious Irritable Bowel Syndrome After a Food-Borne Outbreak of Acute Gastroenteritis Attributed to a Viral Pathogen.
5:457-460.
2007
-
Consensus Development Conference on the Use of Nonsteroidal Anti-Inflammatory Agents, Including Cyclooxygenase-2 Enzyme Inhibitors and Aspirin.
4:1082-1089.e4.
2006
-
Time Course and Pattern of Blood Loss With Ibuprofen Treatment in Healthy Subjects.
3:1075-1082.
2005
-
Perceptions of Physicians and Patients With Organic and Functional Gastrointestinal Diagnoses.
2:121-126.
2004
-
Perceptions of physicians and patients with organic and functional gastrointestinal diagnoses.
2:121-126.
2004
-
Interim Analysis of a Trial Evaluating the Utility of Non-Targeted Biopsies for Colorectal Neoplasia Detection in Inflammatory Bowel Disease
2024
has subject area
Identity
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)